Push to put all asthma patients on preventers

A revolutionary treatment model for asthma should replace intermittent salbutamol for mild asthma with long-term, low-dose inhaled corticosteroids (ICS) for all, proponents say.

Professor Helen Reddel (pictured) of the Woolcock Institute  of Medical Research in Sydney has proposed that asthma be managed with a population-based risk reduction approach, similar to the way hypertension and hypercholesterolaemia are treated.

Instead of relying on as-needed short-acting relievers for infrequent symptoms, all patients with mild, intermittent asthma would take a